Composition and method for treating, relieving or preventing neuropathic pain, containing choline alfoscerate as active ingredient
US11311561B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2018 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Dec 10, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0053
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Choline alfoscerate is useful for treating cognitive dysfunction associated with cerebrovascular diseases and degenerative brain diseases. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with neuropathic pain, it can significantly reduce the pain intensity and the occurrence of neuropathic pain. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing neuropathic pain and a health functional food composition for improving neuropathic pain and may also be used for a method for treating neuropathic pain by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating neuropathic pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.